HomeTrading IdeasGold Retreats as Israel-Iran...

Gold Retreats as Israel-Iran Ceasefire Calms Geopolitical Fears, Eyes on Fed

Gold Declines as Middle East Conflict De-escalates

Gold prices () fell towards $3,350 on Tuesday, pressured by easing geopolitical tensions in the Middle East.

The precious metal, typically seen as a safe-haven asset during geopolitical uncertainty, lost some appeal following the announcement of a ceasefire between Israel and Iran. The resolution significantly reduced immediate risk premiums priced into the market, prompting investors to return to riskier assets.

The de-escalation followed late Monday remarks from US President Donald Trump, who confirmed that Iran had agreed to an immediate ceasefire, with Israel expected to follow 12 hours later. The agreement came after Iran launched a symbolic retaliatory strike on a US base in Qatar, which resulted in no casualties. Markets interpreted the limited scope of the response and the swift move toward de-escalation as a sign that both sides were aiming to avoid a broader confrontation.

XAU/USD continued falling during the Asian and early European trading sessions. Market participants are now shifting focus to monetary policy developments, particularly the upcoming testimony by Federal Reserve (Fed) Chair Jerome Powell before Congress. Powell’s testimony on Tuesday and Wednesday is expected to provide further clarity on the Fed’s policy stance amid persistent concerns and mixed economic data. Any hints of rate cuts or shifts in policy trajectory could further influence the direction of gold prices. Key levels to watch are support at $3,340 and resistance at $3,400.

Euro Rises on Expectations of Dovish Fed Rhetoric

The euro () gained 0.49% against the (USD) on Monday. EUR/USD rose after dovish remarks from Federal Reserve (Fed) Governor Michelle Bowman, who suggested that the central bank may soon need to consider interest rate cuts.

Bowman’s shift in tone was particularly notable, given her traditionally hawkish stance on monetary policy. She highlighted concerns over a weakening labour market and appeared less concerned about inflationary pressures from trade tariffs, signalling a potential pivot towards policy easing. Her comments sparked a sell-off in the US dollar (USD), as markets interpreted them as a strong indication that rate cuts could happen sooner than expected. Helen Given, Director of Trading at Monex USA, emphasised the impact of Bowman’s comments, noting that her hawkish reputation made the dovish shift especially impactful.

“Any indication that she’s leaning toward rate cuts is enough to put downward pressure on the dollar”, Given said.

Broader geopolitical relief also supported the rise of the euro. Investors expect Iran’s response to recent US strikes on its nuclear infrastructure to be measured and contained, further diminishing safe-haven demand for the US dollar.

Meanwhile, eurozone economic data added another layer of complexity to the global monetary outlook. Flash Purchasing Managers’ Index (PMI) data indicated a steeper-than-expected contraction in private sector activity. This reinforced expectations that the European Central Bank will implement a 25-basis-point in September, potentially lowering the deposit rate to around 1.75%. Despite the eurozone’s soft data, the dovish shift in the Fed’s rhetoric provided enough contrast to keep the US dollar under pressure in Monday’s trading session.

EUR/USD continued rising during the Asian and early European trading sessions. Today, investors should focus on Fed Chair Jerome Powell’s speech at 5:00 p.m. UTC. Traders are speculating whether he will adopt an unexpectedly dovish stance or maintain a more neutral, balanced approach. Key levels to watch are resistance at 1.16300 and support at 1.14500.

GBP Rises on Expectations of Fed Rate Cut and Middle East De-escalation

The British pound () rose towards 1.35200 on Monday following the de-escalation of the Middle East conflict.

S&P Global’s flash composite for June edged up to 50.7, slightly above expectations and signaling marginal expansion in private sector activity. The manufacturing sector continued to contract but at a slower pace than forecast, while services activity aligned with analyst estimates. While this data provided a modest cushion for the pound, it was insufficient to counteract the broader risk-off sentiment dominating global markets.

U.K. business activity expanded modestly in June, supported by a rise in new orders—the first increase this year—although the broader outlook remained cautious, with employers accelerating job cuts and voicing concern over geopolitical risks. S&P Global’s flash (PMI) for June edged up towards 50.7, slightly above expectations and signalling marginal expansion in private sector activity. The manufacturing sector continued to contract but slower than expected, with services activity matching analyst estimates. The data offered modest support for the pound.

Still, last week’s unexpectedly dovish stance from the Bank of England (BoE) added pressure on GBP. The central bank left rates unchanged, but the internal vote revealed a deeper split than markets anticipated. Three of the nine members of the Monetary Policy Committee favoured an immediate rate cut. The BoE underscored ongoing inflation concerns and highlighted ’two-sided risks’, noting that inflation is likely to remain elevated well into 2025. This cautious tone prompted markets to reassess the likelihood of future rate cuts, putting pressure on the pound.

GBP/USD slightly rose during the Asian and early European trading sessions. Investor attention is now on Federal Reserve Chair Jerome Powell’s upcoming testimony before the US Congress on Tuesday and Wednesday. Markets will be looking for signals on the Fed’s policy trajectory amid mixed economic data. Market expectations for a July rate cut have increased, with the CME FedWatch Tool now indicating a 20% probability of a , up from 14.5% just a day earlier.

Most Popular

More from Author

May Retail Sales Decline Confirms Eurozone’s Struggles in Q2

The -0.7% month-on-month decline in coincided with a -0.3% decline...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact...

Read Now

May Retail Sales Decline Confirms Eurozone’s Struggles in Q2

The -0.7% month-on-month decline in coincided with a -0.3% decline in overall services activity in April. While surveys had previously indicated potential weakness in eurozone services for the second quarter, this concrete data confirms our expectations that growth between April and June may have been...

Can Trump’s ‘Run It Hot’ Plan Trap the Fed and Jolt the Bond Market?

Trump wants to run the economy hot to out of debt. So, what are the implications for markets? The Trump administration’s plan for the next 12 months could look like the following: 1) More tariffs: threaten big tariffs by Aug 1st, and ‘’close deals’’ with higher tariff rates before...

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year, I thought it would be a good idea to review the key areas of analysis for the stock market.Such a review includes my...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities, and equities. Central banks once again take the spotlight, with both the Reserve Bank of Australia (RBA) and the Reserve Bank of New...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...